Correlation Between Syndax Pharmaceuticals and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Spero Therapeutics, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Spero Therapeutics.
Diversification Opportunities for Syndax Pharmaceuticals and Spero Therapeutics
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Syndax and Spero is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Spero Therapeutics
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 0.82 times more return on investment than Spero Therapeutics. However, Syndax Pharmaceuticals is 1.23 times less risky than Spero Therapeutics. It trades about -0.06 of its potential returns per unit of risk. Spero Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 1,680 in Syndax Pharmaceuticals on December 5, 2024 and sell it today you would lose (242.00) from holding Syndax Pharmaceuticals or give up 14.4% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Syndax Pharmaceuticals vs. Spero Therapeutics
Performance |
Timeline |
Syndax Pharmaceuticals |
Spero Therapeutics |
Syndax Pharmaceuticals and Spero Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Syndax Pharmaceuticals and Spero Therapeutics
The main advantage of trading using opposite Syndax Pharmaceuticals and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |